These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Neuroleptic drugs and their action on different neuronal pathways. Ungerstedt U, Herrera-Marschitz M, Forster C. J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):34-7. PubMed ID: 2858478 [Abstract] [Full Text] [Related]
11. Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid. Bishnoi M, Chopra K, Kulkarni SK. Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):451-61. PubMed ID: 17988775 [Abstract] [Full Text] [Related]
12. Tardive dyskinesia presenting as gastrointestinal disorder. Goldberg RJ, Morris PL, Lidofsky S. J Clin Psychiatry; 1990 Jun 15; 51(6):253-4. PubMed ID: 1971823 [Abstract] [Full Text] [Related]
13. Neuroleptic drugs: how to reduce the risk of tardive dyskinesia. DeVeaugh-Geiss J. Geriatrics; 1979 Jul 15; 34(7):59-61, 66. PubMed ID: 36330 [Abstract] [Full Text] [Related]
14. Animal models of tardive dyskinesia--a review. Kulkarni SK, Naidu PS. Indian J Physiol Pharmacol; 2001 Apr 15; 45(2):148-60. PubMed ID: 11480221 [Abstract] [Full Text] [Related]
15. Spontaneous and tardive dyskinesias: clinical and laboratory studies. Casey DE. J Clin Psychiatry; 1985 Apr 15; 46(4 Pt 2):42-7. PubMed ID: 2858480 [Abstract] [Full Text] [Related]
16. Molindone and haloperidol in tardive dyskinesia. Glazer WM, Hafez HM, Benarroche CL. J Clin Psychiatry; 1985 Aug 15; 46(8 Pt 2):4-7. PubMed ID: 2862139 [Abstract] [Full Text] [Related]
17. [Tardive dyskinesias]. Mignot G. Encephale; 1983 Aug 15; 9(2):151-66. PubMed ID: 6139271 [Abstract] [Full Text] [Related]
18. [Physiopathology and curative treatment of tardive dyskinesia]. Wolf MA, Gautier J. Encephale; 1987 Aug 15; 13(5):301-8. PubMed ID: 2892663 [Abstract] [Full Text] [Related]